SCHEMBL29212356

SCHEMBL29212356

CC(C)(C)OC(=O)N(C(=O)OC(C)(C)C)c1ccc(P(C)(C)=O)c2c1OC(F)(F)O2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31270224 0.82 — —
SCHEMBL31270434 0.76 RXFP1 (0.35) —
SCHEMBL29212393 0.69 EPAS1 (0.32) —
SCHEMBL25033220 0.68 GPR119 (0.33) —
SCHEMBL31270355 0.68 GPR119 (0.33) —
SCHEMBL29212336 0.67 — —
SCHEMBL25033104 0.66 CACNA1G (0.35) —
SCHEMBL31270065 0.66 CACNA1G (0.35) —
SCHEMBL31726201 0.65 CSNK1E (0.33) —
SCHEMBL31270262 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400591-A1 COMPOUNDS TARGETING MUTANT OF P53 JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2024-12-05 — — US disclosed
CN-117813295-A Compounds targeting p53 mutants 北京加科思新药研发有限公司 2024-04-02 — — CN disclosed
Send feedback